These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28057790)

  • 41. Cardiovascular proteomics: tools to develop novel biomarkers and potential applications.
    Arab S; Gramolini AO; Ping P; Kislinger T; Stanley B; van Eyk J; Ouzounian M; MacLennan DH; Emili A; Liu PP
    J Am Coll Cardiol; 2006 Nov; 48(9):1733-41. PubMed ID: 17084242
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of cardiac biomarkers in end-stage renal disease.
    Wang AY; Lai KN
    J Am Soc Nephrol; 2008 Sep; 19(9):1643-52. PubMed ID: 18322158
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.
    Zethelius B; Berglund L; Sundström J; Ingelsson E; Basu S; Larsson A; Venge P; Arnlöv J
    N Engl J Med; 2008 May; 358(20):2107-16. PubMed ID: 18480203
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease.
    Rawal S; Manning P; Katare R
    Cardiovasc Diabetol; 2014 Feb; 13():44. PubMed ID: 24528626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Using ST2 in cardiovascular patients: a review.
    Daniels LB; Bayes-Genis A
    Future Cardiol; 2014 Jul; 10(4):525-39. PubMed ID: 25301315
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of Plasma γ' Fibrinogen With Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study.
    Appiah D; Schreiner PJ; MacLehose RF; Folsom AR
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2700-6. PubMed ID: 26494231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: results from the PERTINENT study.
    Ceconi C; Fox KM; Remme WJ; Simoons ML; Deckers JW; Bertrand M; Parrinello G; Kluft C; Blann A; Cokkinos D; Ferrari R
    Atherosclerosis; 2009 May; 204(1):273-5. PubMed ID: 18950770
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Involvement of circulating inflammatory factors in prognosis and risk of cardiovascular disease.
    Haybar H; Shokuhian M; Bagheri M; Davari N; Saki N
    J Mol Cell Cardiol; 2019 Jul; 132():110-119. PubMed ID: 31102585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Application of microRNAs in diagnosis and treatment of cardiovascular disease.
    Wronska A; Kurkowska-Jastrzebska I; Santulli G
    Acta Physiol (Oxf); 2015 Jan; 213(1):60-83. PubMed ID: 25362848
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Cardiovascular and Cerebrovascular Diseases.
    Li M; Zhang J
    Biomed Res Int; 2015; 2015():730535. PubMed ID: 26180810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early markers of cardiovascular risk in chronic kidney disease.
    Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A
    Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biomarkers for cardiovascular disease: challenges and future directions.
    May A; Wang TJ
    Trends Mol Med; 2008 Jun; 14(6):261-7. PubMed ID: 18487087
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating microRNAs and hypertension--from new insights into blood pressure regulation to biomarkers of cardiovascular risk.
    Romaine SP; Charchar FJ; Samani NJ; Tomaszewski M
    Curr Opin Pharmacol; 2016 Apr; 27():1-7. PubMed ID: 26827149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biomarkers in acute cardiovascular disease.
    Howie-Esquivel J; White M
    J Cardiovasc Nurs; 2008; 23(2):124-31. PubMed ID: 18382255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. From Lipids to Inflammation: New Approaches to Reducing Atherosclerotic Risk.
    Shapiro MD; Fazio S
    Circ Res; 2016 Feb; 118(4):732-49. PubMed ID: 26892970
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease.
    Herder C; Karakas M; Koenig W
    Clin Pharmacol Ther; 2011 Jul; 90(1):52-66. PubMed ID: 21654741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CVD-related Fit-Fat Index on inflammatory-based CVD biomarkers.
    Loprinzi PD; Edwards MK
    Int J Cardiol; 2016 Nov; 223():284-285. PubMed ID: 27541674
    [No Abstract]   [Full Text] [Related]  

  • 58. MicroRNAs in cardiovascular disease.
    Siasos G; Bletsa E; Stampouloglou PK; Oikonomou E; Tsigkou V; Paschou SA; Vlasis K; Marinos G; Vavuranakis M; Stefanadis C; Tousoulis D
    Hellenic J Cardiol; 2020; 61(3):165-173. PubMed ID: 32305497
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sexual Dimorphism in Cardiovascular Biomarkers: Clinical and Research Implications.
    Lau ES; Binek A; Parker SJ; Shah SH; Zanni MV; Van Eyk JE; Ho JE
    Circ Res; 2022 Feb; 130(4):578-592. PubMed ID: 35175850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. From circulating biomarkers to genomics and imaging in the prediction of cardiovascular events in the general population.
    Fava C; Montagnana M; Guidi GC; Melander O
    Ann Med; 2012 Aug; 44(5):433-47. PubMed ID: 21623699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.